SSIC 325 MANUFACTURE OF MEDICAL AND DENTAL INSTRUMENTS AND SUPPLIES
Companies in This Category (1,668)
EMBODIED ROBOTICS PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
AMPLINK DIAGNOSTICS PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
SYNERAK MEDTECH HOLDING PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
EASE GLOBE PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
LUMINAID HEALTHCARE PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
PERLUMIS PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
LEAKSENZE PTE. LTD.
Incorporated May 2026
SSIC: 325
Live Company
GACO INTERNATIONAL PTE. LTD.
Incorporated Apr 2026
SSIC: 325
Live Company
VEDABIO ASIA PTE. LTD.
Incorporated Apr 2026
SSIC: 325
Live Company
DEEPSIGHT TECHNOLOGY PTE. LTD.
Incorporated Apr 2026
SSIC: 325
Live Company
MEDBOT AI PTE. LTD.
Incorporated Apr 2026
SSIC: 325
Live Company
P3 BIOTECHNOLOGY PTE. LTD.
Incorporated Apr 2026
SSIC: 325
Live Company
🔒 Free Preview:
You're viewing the first page of results
Related Categories (5)
Understanding SSIC 325
The SSIC 325 classification pertains to manufacture of medical and dental instruments and supplies. This official code is mandatory when registering a business entity with ACRA (Accounting and Corporate Regulatory Authority) in Singapore.
Key Characteristics:
- Compliance with the Singapore Medical Device Regulations (SMDR) under the Health Products Act.
- Often structured as Private Limited Companies (Pte Ltd) due to liability considerations.
- Subject to licensing requirements from the Health Sciences Authority (HSA) for manufacturing and distribution.
Common Business Operations
Manufacture of medical, dental and surgical instruments and apparatus (including artificial joints, teeth and limbs).
Manufacturing of surgical instruments such as scalpels, forceps, and retractors.
Production of dental equipment including drills, chairs, and X-ray machines (as per ACRA's industry examples).
Development and manufacturing of implants and prosthetics, often involving collaboration with research institutions like A*STAR and leveraging Singapore's biomedical manufacturing ecosystem (as highlighted in EDB reports).